Abstract: Pulmonary oedema (PO) can emerge from mechanical disorders in pulmonary circulation leading to elevated fluid filtration in the lung, or from increased vascular permeability due to inflammatory or toxic injury of the alveolarcapillary barrier. A number of these disorders causing PO is associated with increased catecholamine (CA) levels in plasma and lung tissue and/or increased sympathetic activation such as neurogenic PO, high-altitude PO or PO in patients with phaeochromocytoma. Experimental CA stimulation in animals induced PO after less than one hour of infusion. Both -and -adrenergic mechanisms are involved in the pathogenesis but also in the resolution of PO. CAs increase pulmonary capillary pressure and thus, enhance fluid filtration into the pulmonary interstitium. Additionally, by activation of proinflammatory cytokines, they induce pulmonary inflammation that may lead to capillary leak. Finally, they play an important role in the regulation of alveolar fluid clearance. The present paper considers the pathways by which CAs contribute to the development of PO of various origin.
INTRODUCTION
Pulmonary oedema (PO) has usually been classified as hydrostatic or high-permeability oedema. The hydrostatic (also called "cardiogenic") oedema results from elevated fluid filtration due to increased pulmonary capillary pressure. The high-permeability (or "non-cardiogenic") oedema is caused by increased permeability of the capillary wall in the lungs. Typical conditions associated with high-permeability oedema are e.g. pneumonia, endotoxaemia, tumours up to severe lung syndromes like the acute lung injury (ALI) or the acute respiratory distress syndrome (ARDS). These two types can be considered the extremes of the spectrum of PO types. In several conditions, an initially hydrostatic oedema may turn into a high-permeability oedema due to a further increase of the capillary pressure that finally leads to disruption of the alveolo-capillary barrier -a condition that is different from the typical inflammatory or toxaemic high-permeability oedema. Several deficiencies in the traditional binary classification required a more differentiated classification taking into account the manifold processes involved in formation and resolution of pulmonary oedema. A more recent classification distinguishes four types of oedema: 1) hydrostatic oedema, 2) permeability oedema caused by diffuse alveolar damage, 3) permeability oedema without diffuse alveolar damage and 4) mixed hydrostatic and permeability oedema [1] .
The development of neurogenic pulmonary oedema (NPE), high altitude pulmonary oedema (HAPE) and some other types of non-cardiogenic and non-infectious or non-toxaemic oedema such as in patients with phaeochromocytoma is associated with strong sympathetic activation. Although these types of PO have a different aetiology, they share a number *Address correspondence to this author at the Carl-Ludwig-Institute of Physiology, University of Leipzig, Liebigstr. 27, D -04103 Leipzig, Germany; Tel: +49 341 9715514; Fax: +49 341 9715509; E-mail: rasb@medizin.uni-leipzig.de of similar features that point towards common pathways in their pathogenesis. In the present paper, important pathogenic factors involved in formation and resolution of pulmonary oedema are considered with respect to the role of CAs for PO development. In particular, the contribution of -and -adrenergic pathways to oedema formation and resolution as well as to related pathophysiologic processes such as inflammation is investigated.
In the first part of the paper, essential mechanisms involved in the pathogenesis of PO are analyzed. In a second part, results of experimental CA stimulation in the rat are presented with respect to pulmonary injury and oedema. Finally, CA effects are elucidated that might contribute to formation and resolution of PO. The aim is to sketch a common pathway by which CAs contribute to the pathogenesis of PO in different primary disorders. Although the development of cardiac hypertrophy with subsequent transition into left ventricular failure is also associated with increased sympathetic activity and with elevated plasma CA levels [2] , the cardiogenic PO is not considered in this review. Cardiac hypertrophy and transition to cardiac failure are chronic processes with a different time course compared to the events eliciting the other PO types characterised in this study.
PATHOGENIC FACTORS CONTRIBUTING TO PULMONARY OEDEMA

Pulmonary Capillary Pressure
Elevated pulmonary capillary pressure is considered the primary cause of many PO types such as NPE [3] or HAPE [4, 5] . Pulmonary capillary pressure is determined by pulmonary artery and left atrial pressures, pulmonary vascular resistance and pulmonary blood flow [6] . In HAPE, the increase in pulmonary capillary pressure results from hypoxic pulmonary vasoconstriction which predominantly takes place in small muscular pulmonary arteries [7] . Hypoxic constriction of pulmonary veins accounting for about 20% of total hypoxic pulmonary vasoconstriction may additionally in-crease the pressure in the pulmonary capillary bed [8] . Reduced availability of nitric oxide (NO) has also been suggested to be a major cause of exaggerated pulmonary artery pressure [5] . Furthermore, regional overperfusion in the lung resulting from inhomogenous hypoxic pulmonary vasoconstriction [9] contributes to formation of HAPE, particularly in areas with elevated pressure. Indeed, increased heterogeneity in pulmonary blood flow has recently been demonstrated in HAPE-susceptible persons compared to non-susceptible controls [10] .
NPE is considered to result from insults of the central nervous system such as mechanical cerebral compression. These insults evoke a massive sympathetic discharge causing systemic arterial hypertension, increase in total peripheral resistance (TPR), pulmonary venous hypertension and hence, elevated pulmonary capillary pressure [3, 11, 12] . Increased pulmonary capillary pressure due to congestion also accounts for pulmonary oedema formation after CA medication in patients, particularly after administration of -adrenergic agonists. Systemic hypertension due to vasoconstriction increases left ventricular afterload and finally, causes pulmonary congestion [13] . A similar pathogenesis combined with overfilling in the pulmonary circulation is discussed to cause non-cardiogenic oedema in phaeochromocytoma [14, 15] . When the pulmonary blood flow is high, the endothelial surface area, one of the determinants of the capillary filtration coefficient, is increased [16] . Furthermore, mean pulmonary capillary pressure increases with increasing blood flow and becomes progressively closer to arterial than to venous pressure [17] .
Besides the hydrostatic capillary pressure, the oncotic pressure in plasma is one of the Starling forces determining transepithelial fluid movements. Pulmonary oedema may occur in patients with hypoproteinaemia [18] . However, high pulmonary interstitial protein concentration and efficient pulmonary lymph drainage make the lung relatively insensitive to reduction of the colloid-osmotic pressure [19, 20] . Therefore, the hydrostatic capillary pressure is the main determinant of lung fluid balance. Elevated hydrostatic pressure in the pulmonary capillaries causes elevated fluid filtration into the pulmonary interstitium [21] . The lung has several mechanisms to drain excess fluid from the interstitium, e.g. via the lymphatics or into the pleural space [22, 23] . If all these reservoirs are overloaded, the alveoli are flooded according to the all-or-none law [23] .
Capillary Permeability
Increased pulmonary capillary permeability can occur with or without injury to the alveolar wall [1] . Acute respiratory distress syndrome (ARDS) is considered the severest form of permeability oedema characterized by loss of the integrity of the alveolo-capillary barrier. Alveolar epithelial damage is the determining factor and predominates all manifestations of capillary endothelial injury [1] . Without alveolar damage, permeability oedema develops on the basis of minor and reversible changes of the endothelium, e.g. after interleukin (IL)-2 administration [24] . It has been demonstrated in sheep that the alveolar epithelium is significantly more resistant than the capillary endothelium to injuries by E. coli endotoxin [25] .
In numerous cases, PO presents as a mixed hydrostatic and permeability oedema as e.g. in HAPE and NPE [3, 5] . Ultrastructural changes in the alveolo-capillary barrier are superimposed to a primary increase in the hydrostatic capillary pressure [26] . The lesion of the alveolo-capillary barrier is considered to result from increased wall stress due to exaggerated capillary pressures. This condition is termed stress failure and may occur in a variety of clinical conditions such as mitral stenosis, lung overinflation, HAPE, NPE or exercise-related oedema in athletes [27] . It may concern the capillary endothelial layer, the alveolar epithelial layer, or, sometimes, all layers of the wall [26, 28] . In NPE or phaeochromocytoma-related PO, effects of CAs, particularly -adrenergic effects with strong increase in TPR and elevation of cardiac afterload are discussed to finally cause a permeability defect of the alveolo-capillary barrier [3, 14, 29] . Ultrastructural changes in the walls of pulmonary capillaries identical to those observed in stress failure have been demonstrated in a rabbit model of NPE [30] . Congestion or overperfusion in the pulmonary capillaries may further elevate capillary pressure, thus inducing stress failure and increasing vascular permeability [28, 31] . This mechanism is considered to underly the formation of HAPE [5, 32] . As mentioned above, an uneven hypoxic pulmonary vasoconstriction may cause overperfusion in some areas of the lung and thus, exaggerate capillary pressure [9] . Increased heterogeneity of lung perfusion under conditions of hypoxia has been demonstrated in pigs using microspheres [33] . This is also supported by the patchy pattern of the early HAPE on radiographs [5] . However, stress failure may not solely contribute to the high permeability in HAPE and might be only a late manifestation [34] . It has recently been shown that acute hypoxia per se can cause pulmonary oedema with increased permeability even at low pulmonary perfusion pressures by increasing hydraulic conductance of the vascular endothelium [35] . A contribution of inflammatory processes to the development of HAPE has been controversially discussed. Neutrophil activation and elevated concentrations of proinflammatory cytokines were found in the bronchoalveolar lavage (BAL) fluid of HAPE patients [32, 36, 37] . Other studies, however, disproved involvement of inflammation in the pathogenesis of HAPE [34, 38] .
Removal of Excess Fluid from the Pulmonary Interstitium and Alveolar Fluid Clearance
Oedema formation does not only depend on transudation or exudation from the capillaries into the surrounding tissue but also by fluid removal from the interstitium. The bloodgas barrier of the human lung is extremely thin. This is necessary for the gas exchange through the barrier. The interstitium of the lung has only a limited capacity of fluid accumulation being about 30ml of excess fluid per 100g of wet lung tissue [39] . Low capillary permeability, low tissue compliance and an efficient lymphatic drainage keep the lung interstitium relatively dry [40] . The low compliance of the lung interstitium which is about 20-fold lower than that of other tissues is considered an important "tissue safety factor" [41] . When the pulmonary interstitium takes up fluid filtrated from the capillaries, the interstitial hydrostatic pressure rapidly increases from subatmosphaeric values of about -10cmH 2 O to positive values up to +4 cmH 2 O [42] . With further accumulation of fluid, the interstitial pressure drops to zero and remains unchanged despite progression of fluid filtration indicating an increase in tissue compliance and thus, a reduction of the tissue safety factor [40] . Proteoglycans and hyaluronan are important for the ability of the pulmonary interstitial matrix to hold small amounts of extravascular fluid [42, 43] . Reduced interaction and fragmentation of proteoglycans result in a loss of structural organization of the extracellular matrix. Finally, the tolerance of the extracellular matrix to volume loading is exceeded as reflected in a fully developed interstitial oedema [42] .
The lung has several ways to remove excess fluid from the interstitium. If the pulmonary capillary pressure has returned to normal, the fluid can be reabsorbed into the vascular bed [44] . Most of the interstitial fluid is drained via the lymphatics [22] . Furthermore, fluid can be soaked up by the peribronchovascular tissue and then, drained into the mediastinum or filtrated into the pleural space [23] . The pleural space provides an important contribution to the clearance of fluid from the interstitium. In sheep with experimental highpermeability oedema, the volume of pleural fluid was about 21% of the excess lung fluid [45] . If the capacity of all compensatory mechanisms is exceeded, leakage of the alveolocapillary membrane develops and finally, interstitial fluid breaks through the alveolar wall [23] .
Moreover, the lung is capable to clear fluid from the alveoli. Active sodium transport is the primary mechanism driving alveolar fluid clearance in the normal lung. Na + enters the alveolar cell at the apical side mainly through amiloride-sensitive ion channels and leaves these cells via active transport through the basolateral membrane by the ouabainsensitive Na + -K + -ATPase [46, 47] . The resulting osmotic gradient is responsible for fluid reabsorption across the epithelium from the alveolar space. Regulation of alveolar fluid clearance includes both CA-dependent and -independent mechanisms. Na + transport is increased by -adrenergic stimulation, particularly by 2 -adrenergic agonists [48, 49, 50] . Positive preventive and therapeutic effects of 2 -adrenergic drugs such as salmeterol and albuterol in humans were reported, e.g. in patients with HAPE [51] and in ventilated patients with ARDS [52] . Among CA-independent mechanisms, hormonal factors such as glucocorticoids or proinflammatory molecules have been shown to upregulate Na + uptake and fluid transport [46, 53] . Additionally, chloride transport across alveolar epithelium contributes to Na + reabsorption and fluid clearance [54] . Both alveolar epithelial type I and type II cells as well as distal airway epithelia are involved in Na + and fluid transport. [55] .
The epithelia of the alveoli and the distal airways are resistant to injury. In mild or moderate lung injury with endothelial damage and interstitial oedema but intact alveolar epithelium, the alveolar Na + and fluid transport capacity is not only preserved but may even be upregulated [56] . Various mechanisms contribute to the upregulation of alveolar fluid clearance, e.g. catecholamines. They can stimulate the activity and expression of the epithelial Na + channel and of the Na + -K + -ATPase [57, 58, 59] . Impairment of the alveolar epithelial fluid transport has often been found in patients with high permeability oedema and severe lung injury. However, reduced alveolar fluid reabsorption could also be demonstrated in animal models of increased pulmonary vascular pressures [60, 61] . Injury of the alveolar epithelium such as after acid aspiration increases the protein permeability of the epithelium and considerably reduces alveolar fluid clearance [56] . Hypoxia also inhibits fluid reabsorption by decreasing activity and expression of Na + transport proteins in cultured alveolar epithelial cells [62] . Studies in animals confirmed a decrease of alveolar Na + and fluid transport in hypoxia [63, 64] . Reduced activity of alveolar reabsorption has been found in HAPE-susceptible subjects [51, 65] indicating that hypoxia-related reduction of alveolar fluid clearance is involved in the pathogenesis of HAPE.
LUNG INJURY AFTER EXPERIMENTAL CATE-CHOLAMINE STIMULATION IN RATS:
In rats, intravenous norepinephrine (NE) infusion induced blood accumulation in the lungs as evidenced by scintiphotography. The congestion in the lungs was suggested to result from a generalised systemic vasoconstriction. As a consequence, the animals developed PO and haemorrhage [11] . A single injection of adrenaline at a dose of 0.1mg/kg in rats caused severe PO with cyanosis and respiratory distress and finally, death of all animals within 20 minutes after injection [66] . A similar outcome was described after intravenous phenylephrine (PE) injection with the mortality rate depending on the PE dose [67] . Continuous intravenous infusion of 0.1mg/kg/h NE also induced interstitial PO after 90 min but all animals survived this period [68] . After 6h of NE infusion, pleural effusion had developed which has been thought to prevent large affection of the alveoli [69] . -Adrenergic stimulation with PE or with NE combined with the -adrenergic blocker propranolol accelerated oedema formation. These animals showed only small amounts of pleural fluid but developed strong alveolar oedema after several hours of infusion [70] . Protein-rich alveolar and interstitial oedema associated with increased capillary permeability was also observed by Dai et al. [66] after adrenaline administration. In contrast, -adrenergic stimulation with isoproterenol (ISO) or with NE combined with prazosin induced only mild interstitial oedema and abundant pleural effusion which occurred after 16-24h [70] . After that time, PO was followed by inflammation that was generalised after -adrenergic stimulation and confined to the peribronchial areas afteradrenergic treatment. In -adrenergically treated animals, it was accompanied by an increase in protein concentration in the BAL fluid indicating a permeability defect in the alveolar-capillary barrier. This points towards a transition to exudation and is suggested to result from inflammation. After -adrenergic infusion, protein concentration increased only in pleural fluid. We would therefore conclude that haemodynamic changes resulting in an elevated pulmonary capillary pressure were the primary factor inducing oedema whereas inflammation in the lungs developed later and maintained and aggravated the oedema. Despite continued stimulation, oedema resolution set in after one day, and the most part of oedema was resolved within three days of infusion [70] (Fig.  (1) ).
EFFECTS OF CATECHOLAMINES ON FORMA-TION AND RESOLUTION OF PULMONARY OE-DEMA
The finding that elevated levels of CAs may cause PO is very old. A study by Rona et al. [71] using ISO as a model for experimental focal cardiac necroses demonstrated development of PO in a dose-dependent manner. Which effects of CAs may account for their contribution to PO formation and resolution?
Haemodynamic Effects
Continuous infusion of NE in rats caused a significant increase in right ventricular systolic pressure (RVSP) after less than 20min [69] . Additionally, NE stimulation elicited a generalised systemic vasoconstriction [11] that was reflected in a significant increase in TPR [69] (Fig. (1) ). In particular, 1 -adrenergic stimulation has been shown to cause both systemic and pulmonary vasoconstriction [72, 73, 74] . Since the smaller pulmonary veins are supplied with noradrenergic fibres [75] , also the pulmonary venous tone can be increased by NE [76] . As a consequence of this vascular effect in concert with the elevated RVSP, large amounts of blood are shifted into the lungs [12, 66] . Systemic vasoconstriction is one of the main causes of increased pulmonary blood volume [77] which finally results in pulmonary capillary congestion. When serum levels of NE are elevated due to experimental infusion or sympathoexcitation, -adrenergic effects dominate as can be concluded from comparing the effects of NE and PE infusion. With both -and -adrenergic stimulation, haemodynamic changes and formation of PO in rats developed in a similar way but this was faster and more severely with the -adrenergic agonist PE compared to ISO [70] . -Adrenergic stimulation with ISO induced a much more pronounced increase in RVSP [70] . In the pulmonary circulation, particularly stimulation of 2 -adrenoceptors causes vasodilation [78, 79] and thus, elevated capillary blood flow might result. Another potent vasodilator in the tracheobronchial and pulmonary circulation is NO which is continuously produced in the respiratory system [80] . Recent studies in rabbits demonstrated that administration of 2 -adrenergic agonists and even more 1 -adrenergic agonists stimulate pulmonary NO production [81] . Sympathetic activation enhanced and 1 -adrenoceptor antagonists significantly reduced NO production in the lung indicating involvement of -adrenergic mechanisms in the endogenous regulation of pulmonary NO production [82] .
Pulmonary Fluid Filtration and Capillary Permeability
Elevated CA concentrations can damage the integrity of the pulmonary capillaries and increase the capillary permeability [3, 15, 83, 84] . In animal models, this effect has been shown to be caused by 1 -adrenergic [67] as well as by 2 -adrenergic stimulation [85] . Correspondingly, we observed high protein concentrations in the BAL fluid after -adrenergic stimulation with NE, PE or NE in combination with propranolol, but not after infusion of ISO or NE combined with the 1 -adrenergic antagonist prazosin [70] . A study by Parker and Ivey [86] suggested that active control maintains the normal capillary permeability during exposure to elevated vascular pressure. -Adrenergic mechanisms are probably involved in this control and are thought to reduce epithelial and endothelial conductance. This has been shown with ISO administration that reduced capillary filtration in isolated rat lungs exposed to elevated venous pressure. Moreover, ISO is assumed to induce closure of endothelial and epithelial breaks [86] . These findings indicate that increased permeability of the alveolo-capillary barrier is related to -but not to -adrenergic mechanisms (Fig. (1) ).
Application of -adrenergic blockers prevented both experimental CA-induced PO and NPE [69, 87] . A study on the effects of different -adrenergic agonists and antagonists on formation and prevention of PO revealed that induction of oedema strictly depended on activation of 1 -adrenoceptors [67] . 1 -Adrenergic antagonists were successfully administered in phaeochromocytoma patients for treatment of PO [14, 83] . In contrast, administration of the -blocker propranolol even induced PO in phaeochromocytoma patients [88] .
Activation of Cytokines and Inflammation
CAs exert stimulatory effects on proinflammatory cytokines such as IL-1 and IL-6 [89, 90] . In particular, -adrenergic mechanisms are associated with activation of IL-1 , tumour necrosis factor [91] and IL-6 [92, 93] (Fig. (1) ). IL-6 activation has been discussed to be involved in the pathogenesis of pulmonary injuries preceded by sympathetic activation such as HAPE [32, 36, 37] . Pulmonary inflammation associated with elevated CA concentrations in serum has been repeatedly observed in different stress situations such as haemorrhage [91, 94] , lipopolysaccharide administration [94] or electrical stimulation [95] . Stress and CAs also affect number and function of inflammatory cells [91] . CA-induced neutrophilia is mainly mediated via 1 -adrenoceptor stimulation whereas -adrenergic stimulation induces lymphocytosis that, in contrast, is counterregulated by -adrenergic mechanisms [91] . Numerous anti-inflammatory effects of -adrenergic agonists have been shown, e.g. attenuation of proinflammatory cytokine expression [96, 97] . In rats, both infusion of -and -adrenergic agonists induced an inflammatory response in the lung. However, after PE infusion, a strong generalised pulmonary inflammation with significant neutrophilia in BAL developed within 24h whereas ISO in-fusion caused only focal peribronchial inflammation without changes in BAL cytology [70, 90] . The time sequence of haemodynamic changes, oedema formation and inflammation suggests that pulmonary oedema after experimental CA application is primarily a hydrostatic oedema induced by haemodynamic consequences of CA stimulation. With further stimulation, particularly with -adrenergic agonists, a permeability defect might develop as suggested by the protein-rich BAL fluid. Inflammatory reactions induced by CAs may aggravate the oedema and prolong its persistence, but they are rather consequence than cause of oedema.
Resolution of Excess Fluid from Pulmonary Interstitium
An efficient lymphatic drainage is an important factor in keeping the lung interstitium at a low fluid volume. The smooth muscle tone of tracheobronchial lymph vessels has been found to exhibit a similar NO-dependent relaxation as blood vessels [98] . As pulmonary NO production is enhanced by -adrenergic mechanisms [81] , it can be speculated that stimulation of -adrenergic receptors might also dilate tracheobronchial lymph vessels. -Adrenergic receptors were found in the smooth muscle of the canine thoracic ). On the left hand side, the pathogenic factors are presented. Haemodynamic changes (increase in RVSP and/or TPR) resulting in elevated pulmonary capillary pressure are the primary factor in oedema formation. With longer stimulation, inflammation in the lungs develops, particularly after -adrenergic treatment. The inflammation is assumed to maintain and to aggravate the oedema by increasing capillary permeability. Inflammation is considered to be rather a consequence than a cause of the oedema. With -adrenergic stimulation, only interstitial oedema developed whereas infusion of -adrenergic agonists elicited severe alveolar oedema after several hours.
On the right hand side, the protective mechanisms are shown. Excess fluid is removed from the interstitium by reabsorption into the vasculature, lymph drainage and filtration into the pleural space. Alveolar fluid clearance eliminates fluid from the air space. This function is upregulated under -adrenergic stimulation, thus accelerating oedema resolution.
RVSP: right ventricular systolic pressure, TPR: total peripheral resistance, : increase. duct causing contraction after stimulation [99] suggesting that sympathetic innervation of lymphatic vessels might affect the lymphatic drainage from the lungs.
Both pulmonary endothelial and interstitial cells are vulnerable to injury from -blockade. Continuous application of -blockers stimulated apoptosis of endothelial cells and induced a fibrogenic response with an increase in interstitial cells [100, 101] . The increased matrix deposition is assumed to decrease the compliance of the interstitium and thus, to enhance the tissue safety factor [40] . Accordingly, it was shown in experimental pulmonary fibrosis that oedema fluid is redistributed from the interstitium to the alveoli [102] . This might contribute to the alveolar oedema observed in rats after stimulation with -adrenergic agonists or with NE combined with the -blocker propranolol [70] .
Pleural effusions particularly develop in the presence of pulmonary venous hypertension [103] . This may account for pleural effusions observed in our studies on CA-treated rats. NE infusion increased RVSP and TPR which are assumed to cause pulmonary venous hypertension and capillary congestion [69] . In rats stimulated with ISO, the elevated RVSP in combination with pulmonary vasodilation may have increased pulmonary venous pressure via blood overfilling in the pulmonary circulation [70] .
Alveolar Fluid Clearance
CAs play an important role for the upregulation of alveolar fluid clearance. Animal studies showed a stimulating effect of epinephrine on liquid clearance in the lung [48, 104] . In particular, 2 -adrenergic stimulation has often been reported to increase the alveolar epithelial Na + and fluid transport [49, 50, 63] (Fig. (1) ). Alveolar epithelial cells can produce dopamine which increases Na + -K + -ATPase activity and thus, enhances the active Na + transport [105] . Minakata and colleagues [58] demonstrated that CAs, particularly -adrenergic agonists, can modulate the expression of the epithelial sodium channel and of the Na + -K + -ATPase. Upregulation of the active Na + transport also involves the cystic fibrosis transmembrane conductance regulator (CFTR), andadrenergic regulation of alveolar active Na + transport may be mediated via a CFTR dependent pathway [106] .
After mild to moderate lung injuries in rats, increased alveolar fluid clearance was observed that could be inhibited by instillation of propranolol into the distal air spaces [107] . Adrenal epinephrine increased alveolar fluid clearance in a canine model of NPE suggesting acceleration of oedema resolution in NPE patients by endogenous epinephrine [108] . These findings point towards an endogenous -adrenergic stimulation of the alveolar epithelial Na + transport. Therapy with exogenous 1 -and 2 -adrenergic agonists has also been shown to enhance alveolar fluid clearance [51, 109, 110] . In a recent study, a stimulating effect on alveolar fluid clearance of 1 -adrenergic agonists has been presented whereas 2 -adrenoceptor activation had no effect [111] . However, prolonged infusion with ISO can impair the 2 -adrenergic stimulation of alveolar fluid clearance and produce downregulation of -adrenoceptors [112] . The -adrenergic upregulation of alveolar fluid clearance can also be reduced by activation of -adrenoceptors and can be restored byadrenergic antagonists. In experimental hemorrhagic shock, these effects were related to modulation of the associated pulmonary inflammation [92] . In CA-treated rats, we observed that alveolar oedema occurred only after NE or PE infusion but never after -adrenergic stimulation [70] -a finding that is consistent with these reports. Althoughadrenergic stimulation can induce pulmonary oedema and peribronchial inflammation in rats, this lung injury developed less rapidly and was less severe than lung oedema and inflammation induced by -adrenergic stimulation.
CONCLUSION
In the present paper, some important pathogenic factors involved in the formation and resolution of PO and their contribution to the development of PO types associated with strong sympathetic activation and/or high plasma concentrations of CAs are reviewed. Findings from experimental CA stimulation in rats are characterised with particular respect to lung injury and pulmonary oedema. Despite different aetiologies these types of oedema share a number of similarities in their pathogenesis. We suggest that CAs might contribute to some of their common features. Although both -andadrenergic pathways may be involved in the development of oedema and inflammation, their role in development and prevention of pulmonary oedema shows large differences. Acuity and severity of pulmonary injury, in particular, rapidity of oedema formation, affection of alveoli and generalisation of inflammation, depend on the relative contribution of -and -adrenergic mechanisms to the pathogenic process. In general, predominance of -adrenoceptor activation causes a rapidly progressing severe pulmonary injury with strong alveolar oedema. A mainly -adrenergic stimulation has numerous protective effects. Hence, possible lung injuries develop more slowly and are less severe with oedema being confined to the pulmonary interstitium.
The effects of a stimulation of -and -adrenergic mechanisms are depicted in Fig. (1) : The primary factor for induction of pulmonary oedema are haemodynamic changes (increase in RVSP and/or TPR) resulting in an elevated pulmonary capillary pressure and pulmonary oedema after a few hours. With longer stimulation, inflammation in the lungs developed, particularly (as generalised pulmonary inflammation) after -adrenergic treatment. The inflammation is assumed to maintain and to aggravate the oedema by increasing capillary permeability. However, it is considered to be rather a consequence than a cause of the oedema. Despite continued stimulation, oedema resolution set in after one day, and the most part of oedema was resolved within three days of infusion. CAs modulate the mechanisms of removing fluid from the interstitium and from the alveoli. In general, -adrenergic stimulation is mostly considered to reduce fluid removal whereas -adrenergic mechanisms improve pulmonary fluid transport, particularly alveolar fluid clearance. 
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